Potential for False Positive Results with Abbott Molecular Inc. Alinity m SARS-CoV-2 AMP and Alinity m Resp-4-Plex AMP Kits
The FDA has issued an alert on September 17, 2021, regarding the potential for false-positive COVID-19 testing results using certain kits manufactured by Abbott Molecular Inc. Letter to Clinical Laboratory Staff and Health Care Providers: The U.S. Food and Drug Administration (FDA) is alerting clinical laboratory staff and health care providers of the potential for …
